New hope for chinese patients with stubborn myeloma: experimental drug shows promise
NCT ID NCT05228470
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 23 times
Summary
This study tested a new medicine, elranatamab, in 39 Chinese adults with multiple myeloma that stopped responding to several standard treatments. The drug works by helping the body's immune system attack the cancer cells. The goal was to see if the drug is safe and can shrink or slow the cancer. Participants received injections and were monitored for about 2 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Gaobo Boren Hospital
Beijing, 100070, China
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, 350001, China
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
-
Harbin First Hospital
Harbin, Heilongjiang, 150010, China
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 150081, China
-
Hematology Hospital, Chinese Academy of Medical Sciences
Tianjin, 300020, China
-
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, 210008, China
-
Peking Union Medical College Hospital
Beijing, 100730, China
-
Peking University Third Hospital
Beijing, 100191, China
-
Shandong Provincial Hospital
Jinan, Shandong, 250021, China
-
Shenzhen Second People's Hosptial
Shenzhen, Guangdong, 518035, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510555, China
-
The First Affiliated Hospital of College of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310003, China
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
Conditions
Explore the condition pages connected to this study.